摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 5-chloro-6-(4-(methyl(phenyl)carbamoyl)piperazin-1-yl)nicotinate | 1310537-01-9

中文名称
——
中文别名
——
英文名称
ethyl 5-chloro-6-(4-(methyl(phenyl)carbamoyl)piperazin-1-yl)nicotinate
英文别名
ethyl 5-chloro-6-[4-[methyl(phenyl)carbamoyl]piperazin-1-yl]pyridine-3-carboxylate
ethyl 5-chloro-6-(4-(methyl(phenyl)carbamoyl)piperazin-1-yl)nicotinate化学式
CAS
1310537-01-9
化学式
C20H23ClN4O3
mdl
——
分子量
402.881
InChiKey
FRBSOHBKGYVKPB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    66
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor
    摘要:
    A novel series of P2Y(12) antagonists for development of drugs within the antiplatelet area is presented. The synthesis of the piperazinyl-pyridine urea derivatives and their structure-activity relationships (SAR) are described. Several compounds showed P2Y(12) antagonistic activities in the sub-micromolar range. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.03.088
点击查看最新优质反应信息

文献信息

  • A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor
    作者:Peter Bach、Jonas Boström、Kay Brickmann、J.J.J. van Giezen、Ragnar Hovland、Annika U. Petersson、Asim Ray、Fredrik Zetterberg
    DOI:10.1016/j.bmcl.2011.03.088
    日期:2011.5
    A novel series of P2Y(12) antagonists for development of drugs within the antiplatelet area is presented. The synthesis of the piperazinyl-pyridine urea derivatives and their structure-activity relationships (SAR) are described. Several compounds showed P2Y(12) antagonistic activities in the sub-micromolar range. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多